Maximum standardized uptake value at pre-treatment PET in estimating lung cancer progression after stereotactic body radiotherapy
Jisun Park, Yunseon Choi, Ki Jung Ahn, Sung Kwang Park, Heunglae Cho, Ji Young Lee
Radiat Oncol J. 2019;37(1):30-36.   Published online 2019 Mar 31     DOI: https://doi.org/10.3857/roj.2019.00010
Citations to this article as recorded by Crossref logo
SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
Yoo-Kang Kwak, Hee Hyun Park, Kyu Hye Choi, Eun Young Park, Soo Yoon Sung, Sea-Won Lee, Ji Hyun Hong, Hyo Chun Lee, Ie Ryung Yoo, Yeon Sil Kim
Cancer Research and Treatment.2020; 52(1): 85.     CrossRef
Facteurs de récidive après radiothérapie stéréotaxique des cancers bronchiques non à petites cellules
S. Yossi, D. Nguyen, S. Krhili, T. Lizée, M. Khodri
Cancer/Radiothérapie.2020; 24(3): 267.     CrossRef
Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis
Tae-Hyung Kim, Sungmin Woo, Darragh F. Halpenny, Yeon Joo Kim, Soon Ho Yoon, Chong Hyun Suh
European Journal of Radiology.2020; 127: 108978.     CrossRef
Impact of positron emission tomography with computed tomography for image-guided radiotherapy
V. Isnardi, S. Thureau, P. Vera
Cancer/Radiothérapie.2020; 24(5): 362.     CrossRef